Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 13/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MPO | P05164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19380925 | 0.87 | DHFR (0.48) | DHFRMEN1NPC1MAPTMAPK1 | |
| SCHEMBL20515400 | 0.86 | DHFR (0.52) | DHFRMEN1MAPK1KMT2AMPO | |
| SCHEMBL18618864 | 0.86 | DHFR (0.52) | DHFRMEN1MAPK1KMT2AMPO | |
| SCHEMBL20672109 | 0.80 | MAPT (0.44) | MEN1NPC1MAPTMAPK1RAB9A | |
| SCHEMBL18618861 | 0.79 | DHFR (0.67) | DHFRPKMMPO | |
| SCHEMBL19295489 | 0.79 | MAPT (0.48) | MEN1NPC1MAPTMAPK1RAB9A | |
| SCHEMBL18618821 | 0.79 | MPO (0.47) | DHFRMEN1NPC1MAPTMAPK1 | |
| SCHEMBL20515396 | 0.79 | MPO (0.47) | DHFRMEN1NPC1MAPTMAPK1 | |
| SCHEMBL20515403 | 0.78 | MPO (0.54) | DHFRMEN1NPC1MAPTRAB9A | |
| SCHEMBL18620547 | 0.78 | MPO (0.54) | DHFRMEN1NPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017040451-A1 | TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-03-09 | — | — | WO | disclosed |